CEVAC NEW L ΛΥΟΦΙΛΟΠΟΙΗΜΕΝΟ ΥΛΙΚΟ ΓΙΑ ΕΝΑΙΩΡΗΜΑ
CEVAC NEW L ΛΥΟΦΙΛΟΠΟΙΗΜΕΝΟ ΥΛΙΚΟ ΓΙΑ ΕΝΑΙΩΡΗΜΑ
Authorised
- Newcastle disease virus, strain La Sota, Inactivated
Product identification
Medicine name:
CEVAC NEW L ΛΥΟΦΙΛΟΠΟΙΗΜΕΝΟ ΥΛΙΚΟ ΓΙΑ ΕΝΑΙΩΡΗΜΑ
Active substance:
- Newcastle disease virus, strain La Sota, Inactivated
Target species:
-
Chicken
Route of administration:
-
Oral use
-
Ocular use
Product details
Active substance and strength:
-
Newcastle disease virus, strain La Sota, Inactivated5.50/50% Embryo Infective Dose/dose1.00Dose
Pharmaceutical form:
-
Lyophilisate for suspension
Withdrawal period by route of administration:
-
Oral use
-
Chicken
-
Meat and offal21day
-
-
-
Ocular use
-
Chicken
-
Meat and offal21day
-
-
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Greece
Package description:
- Available only in Greek
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Complete application (stand-alone)
Marketing authorisation holder:
- Ceva Sante Animale
Marketing authorisation date:
Manufacturing sites for batch release:
- CEVA-Phylaxia Zrt.
Responsible authority:
- National Organization For Medicines
Authorisation number:
- 5302/08-08-2002/K-0145801
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
